In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1896 News Items found
Kathryn Anderson
A Final Discovery From the Lab of Dr. Kathryn Anderson: How Signals in the Embryo Tells Cells What To Become

The final paper from the lab of the late MSK Developmental Biology Chair Kathryn Anderson reveals how a critical signaling molecule called WNT guides cells in the embryo from a state of high flexibility — known as "plasticity" — toward distinct, specialized identities. Completing it was a labor of love for her colleagues.
Andrea Schietinger
Rare Stem T Cells May Hold the Key to Fighting Chronic Diseases

A team of scientists from MSK and Weill Cornell Medicine found a small subset of T cells, called stem T cells, are responsible for making new T cells and for continuously replenishing them in chronic disease. The findings open the door to new treatment strategies for chronic conditions like cancer, autoimmune diseases, and infections.
Dr. Sandra D'Angelo
In the Clinic
FDA Grants Full Approval to Engineered Cell Therapy for Treating Rare Sarcoma

The FDA has granted full approval for an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials resulting in the drug’s approval were led by Dr. Sandra D’Angelo of MSK.
Christina and Kevin walk down stairs. Christina is wearing a blue dress and carrying a bouquet. Kevin is wearing a tuxedo.
FDA Approves New Treatment for Triple-Negative Breast Cancer

The FDA has approved the targeted therapy datopotamab deruxtecan (Datroway® or Dato-DXd) for triple-negative breast cancer based on clinical research led by MSK.
An MSK researcher points at a medical image
MSK Research Highlights, June 19, 2026

New MSK research investigates how a natural antifungal compound produced by helpful gut bacteria might help protect vulnerable patients; finds that a protein “fingerprint” in blood could predict dangerous clots in cancer patients; uncovers Americans’ changing relationship with dietary supplements; and reveals how NK cells respond to infections so quickly.
MSK urologic surgeon Dr. Massimiliano Spaliviero
New Prostate Cancer Treatments Aim to Reduce Deaths and Avoid Side Effects

Read about MSK's personalized approach to diagnosing and treating prostate cancer. This includes expertise in determining whether active surveillance is the best option for low-risk disease and providing the newest treatments for people at higher risk.
Lorenz Studer, Danwei Huangfu, Ting Zhou, Thomas Vierbuchen
MorPhiC: Inside the Ambitious Project To Understand the Function of Every Human Gene

MSK scientists are part of an international consortium working to determine the biological functions of the roughly 20,000 protein-coding genes in the human genome.
detail of a scientist holding up a slide
MSK Research Highlights, June 11, 2026

New MSK research decodes how mesothelioma evades immunotherapy; shows why a common kidney cancer treatment combination falls short; and supports a free, open-source AI-driven drug discovery initiative.
Dr. Eileen O'Reilly seen smiling in an exam room.
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope

Learn how a successful clinical trial for pancreatic cancer in which MSK experts play a leading role is opening a new world of treatment options.
Christine Mayr
MSK Scientists Uncover RNA’s Hidden Role as Protein Chaperone

New MSK research shows the largely overlooked "tail" region of mRNAs helps ensure key regulatory proteins get folded correctly — a fundamentally new understanding of their role.